OpenTME Expands to Three New Cancer Types

We're excited to announce that OpenTME now includes fully analyzed whole-slide images for pancreas, prostate, and stomach cancer, bringing the open dataset to eight indications in total.

We built OpenTME to grow alongside Atlas H&E-TME. Following the addition of these three cancer types to Atlas H&E-TME, we've added 1,057 new whole-slide images to OpenTME — 209 for pancreas, 448 for prostate, and 400 for stomach. The expansion lifts coverage from roughly 50% to around 70% of invasive cancer cases, and we plan to surpass 90% by the end of 2026.

As with the rest of OpenTME, each image arrives with pre-computed morphological features from Atlas H&E-TME's four-stage pipeline — tissue QC, tissue segmentation, cell detection and classification, and neighborhood analysis. These can be mapped directly with TCGA's genomic, transcriptomic, and clinical data, enabling multimodal analysis out of the box.

This is the next step in an ongoing effort. OpenTME will keep growing alongside Atlas H&E-TME, and more cancer types are on the way.

Academic researchers can request access with an academic email address here. Biopharma teams can request access to OpenTME for commercial use here.